|
Safety and efficacy of Sofosbuvir therapy in chronic hepatitis C patientsof Peshawar, Khyber Pakhtunkhwa, Pakistan |
|---|---|
| รหัสดีโอไอ | |
| Creator | 1. Muhammad Jawad 2. Sobia Attaullah 3. Sanaullah khan 4. Faheem Ullah 5. Muhammad Zahid 6. Faisal Saeed 7. Ayesha Rizwan 8. Abdul Wahab |
| Title | Safety and efficacy of Sofosbuvir therapy in chronic hepatitis C patientsof Peshawar, Khyber Pakhtunkhwa, Pakistan |
| Publisher | Research and Development Office, Prince of Songkla University |
| Publication Year | 2565 |
| Journal Title | Songklanakarin Journal of Science an Technology (SJST) |
| Journal Vol. | 44 |
| Journal No. | 3 |
| Page no. | 683-689 |
| Keyword | efficacy, hepatitis C virus, Sofosbuvir, therapy, Peshawar, Pakistan |
| URL Website | https://rdo.psu.ac.th/sjst/index.php |
| ISSN | 0125-3395 |
| Abstract | This study is designed to monitor the rapid virological response (RVR) for 8 weeks and sustained virological response(SVR) for 12 weeks during Sofosbuvir therapy in chronic hepatitis C patients in Peshawar, KPK, Pakistan. A total of 162hepatitis C positive patients were enrolled in this study. After RNA isolation, Quantitative PCR was done to get viral load, andOhn et al., 1997 protocol were used for hepatitis virus different genotypes. Statistical analysis was performed using SPSS. ASample t-test was applied to compare gender and age. Chi Square test was applied to compare the RVR and SVR. In total 162positive hepatitis C patients, 90 were male and 72 were female. High rate 153(94%) of RVR and 158(97%) SVR were achievedduring 8 and 12 weeks of sofosbuvir therapy. High SVR and RVR were achieved in the <30 and 31-40 age groups. High EVR125(99%) by genotype 3 were achieved at 8 weeks of therapy and high SVR 126(100%) by genotype 3 and 28(93%) by genotype1 were achieved at 12 weeks of sofosbuvir therapy. The current study reveals that high RVR and SVR rates were obtained byshortening the SOF therapy's treatment time up to 8 and 12 weeks. We got a 98.7% response rate at the end of the treatment. |
